Making strides toward regulating predatory stem cell products
Over the past decade, a number of U.S. clinics have marketed stem cell products directly to consumers as purported treatment for a host of diseases and injuries. The problem, notes UB faculty member Laertis Ikonomou, is that many of these interventions …